BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8996272)

  • 1. Cutaneous infiltration in acute promyelocytic leukemia.
    Ueda K; Kume A; Furukawa Y; Higashi N
    J Am Acad Dermatol; 1997 Jan; 36(1):104-6. PubMed ID: 8996272
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous herald: leukaemia cutis as presenting manifestation of relapse in acute promyelocytic leukaemia.
    Balasubramanian P; Nampoothiri RV; Goni D; Malhotra P
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29724869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukemia cutis in acute promyelocytic leukemia].
    del Río Garma J; Varela Gómez MR; Torres Carrete JP; Batlle Fonrodona FJ
    Sangre (Barc); 1997 Feb; 42(1):87-8. PubMed ID: 9229813
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapse of acute promyelocytic leukemia in the external auditory canal confirmed by PML/RARA dual-fusion and RARA break-apart fluorescence in situ hybridization.
    Minoda S; Akasaka T; Okanoue Y; Honjo G; Nakagawa M; Ohno H
    Ann Hematol; 2018 May; 97(5):909-911. PubMed ID: 29387977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
    Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
    Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extramedullary relapse in acute promyelocytic leukemia.
    Pagano L; Sica S; Marra R; Storti S; Leone G
    Leuk Lymphoma; 1997 Jul; 26(3-4):417-8. PubMed ID: 9322908
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin infiltration in acute promyelocytic leukemia.
    Nagao K; Kikuchi A; Kawai Y; Kizaki M; Ikeda Y; Nishikawa T
    Dermatology; 1997; 194(2):168-71. PubMed ID: 9094468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.
    Naina HV; Levitt D; Vusirikala M; Anderson LD; Scaglioni PP; Kirk A; Collins RH
    J Clin Oncol; 2011 Jun; 29(18):e534-6. PubMed ID: 21482998
    [No Abstract]   [Full Text] [Related]  

  • 9. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.
    Collins C; Knoderer H
    Pediatr Blood Cancer; 2010 Apr; 54(4):603-5. PubMed ID: 19998465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission of acute promyelocytic leukemia in a very elderly patient after treatment with low dose arsenic trioxide and sequential retinoic acid: a case report.
    Lin J; Zhu H; Li S; Fan H; Lu X
    Ann Hematol; 2014 Feb; 93(2):335-6. PubMed ID: 23719691
    [No Abstract]   [Full Text] [Related]  

  • 11. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolated gingival relapse during complete hematological remission in acute promyelocytic leukemia.
    Haznedaroğlu IC; Ustündağ Y; Benekli M; Savaş MC; Safali M; Dündar SV
    Acta Haematol; 1995; 93(1):54-5. PubMed ID: 7725853
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary relapse of acute promyelocytic leukemia after ATRA.
    Lugassy G; Halperin Y
    Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
    [No Abstract]   [Full Text] [Related]  

  • 15. Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studies.
    Weiss MA; Warrell RP
    Cancer; 1994 Oct; 74(7):1882-6. PubMed ID: 8082094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ATRAC therapy].
    Miyazaki Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():628-31. PubMed ID: 25831836
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment for acute promyelocytic leukemia].
    Fujita H
    Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 19. Central nervous system relapse in acute promyelocytic leukemia.
    Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
    Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
    [No Abstract]   [Full Text] [Related]  

  • 20. Extramedullary disease in APL: a real phenomenon to contend with or not?
    Ganzel C; Douer D
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):63-8. PubMed ID: 24907018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.